A Case of Metastatic Breast Cancer that Responded to Anti-HER2 Therapy with Amplification of the ERBB2 Gene in the FoundationOne®CDx Gene Panel Test after Completion of Standard Therapy

Ueda, Y., Makino, Y., Nishida, T., Ochiai, K., Marutsuka, K., Moriguchi, S., & Otomo, N. (2022). A Case of Metastatic Breast Cancer that Responded to Anti-HER2 Therapy with Amplification of the ERBB2 Gene in the FoundationOne®CDx Gene Panel Test after Completion of Standard Therapy. Journal of Nihon University Medical Association, 81(3), 155–159. https://doi.org/10.4264/numa.81.3_155